Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Arbutus Biopharma Corporation (GB:0SGC)
LSE:0SGC
Arbutus Biopharma (0SGC) Stock Price & Analysis
0 Followers
0SGC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.90 - $3.14
Previous Close$2.49
Volume200.00
Average Volume (3M)3.10K
Market Cap
$415.33M
Enterprise Value$270.72M
Total Cash (Recent Filing)$146.73M
Total Debt (Recent Filing)$2.12M
Price to Earnings (P/E)N/A
Beta0.51
Next Earnings
Aug 03, 2023EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,498
30 Day Avg. Volume3,100
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.47
Enterprise Value/Gross Profit6.94
Enterprise Value/Ebitda-3.89
Forecast
1Y Price Target
$5.33Price Target Upside114.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Arbutus Biopharma News
0SGC FAQ
What was Arbutus Biopharma Corporation’s price range in the past 12 months?
Arbutus Biopharma Corporation lowest stock price was $1.90 and its highest was $3.14 in the past 12 months.
What is Arbutus Biopharma Corporation’s market cap?
Currently, no data Available
When is Arbutus Biopharma Corporation’s upcoming earnings report date?
Arbutus Biopharma Corporation’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
How were Arbutus Biopharma Corporation’s earnings last quarter?
Arbutus Biopharma Corporation released its earnings results on May 04, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.136 by $0.036.
Is Arbutus Biopharma Corporation overvalued?
According to Wall Street analysts Arbutus Biopharma Corporation’s price is currently Undervalued.
Does Arbutus Biopharma Corporation pay dividends?
Arbutus Biopharma Corporation does not currently pay dividends.
What is Arbutus Biopharma Corporation’s EPS estimate?
Arbutus Biopharma Corporation’s EPS estimate is -$0.11.
How many shares outstanding does Arbutus Biopharma Corporation have?
Currently, no data Available
What happened to Arbutus Biopharma Corporation’s price movement after its last earnings report?
Arbutus Biopharma Corporation reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.136. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Arbutus Biopharma Corporation?
Among the largest hedge funds holding Arbutus Biopharma Corporation’s share is Woodline Partners LP. It holds Arbutus Biopharma Corporation’s shares valued at 8M.
---
Arbutus Biopharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.33 (114.06% Upside)
$5.33 (114.06% Upside)
Blogger Sentiment
Bullish
GB:0SGC Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.22%
12-Months-Change
Fundamentals
Return on Equity
-45.22%
Trailing 12-Months
Asset Growth
-19.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arbutus Biopharma Corporation
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
---
Nkarta
―
Scholar Rock Holding
―
Lexicon Pharmaceuticals
―
C4 Therapeutics
―
Poseida Therapeutics
―
---